(Q34966232)

5 August 2017

Resolution of severe pyoderma gangrenosum in a patient with streaking leukocyte factor disease after treatment with tacrolimus (FK 506). (English)

1 reference

5 August 2017

1 reference

9

T E Starzl

1 reference

5 August 2017

8

J J Fung

2 references

ORCID Public Data File 2021

5 August 2017

Muhammad Abu-Elmagd

1

object named as

K Abu-Elmagd

1 reference

5 August 2017

D H Van Thiel

2

1 reference

5 August 2017

B V Jegasothy

3

1 reference

5 August 2017

J C Jacobs

4

1 reference

5 August 2017

P Carroll

5

1 reference

5 August 2017

H Rodriquez-Rilo

6

1 reference

5 August 2017

C D Ackerman

7

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 October 1993

1 reference

Annals of Internal Medicine

5 August 2017

1 reference

5 August 2017

119

1 reference

5 August 2017

7 Pt 1

1 reference

5 August 2017

595-598

1 reference

The in vitro action of hydrocortisone on leucocyte migration

5 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091479

The chemosuppression of chemotaxis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091479

FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091479

Efficacy of FK 506 in the treatment of recalcitrant pyoderma gangrenosum

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091479

Adverse effects associated with the use of FK 506

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091479

Liver, kidney, and thoracic organ transplantation under FK 506.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091479

Tacrolimus (FK 506)--a new therapeutic agent for severe recalcitrant psoriasis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091479

Leukokinesis-enhancing factor in human serum: partial characterization and relationship to disorders of leukocyte migration

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091479

"Streaking leukocyte factor," arthritis, and pyoderma gangrenosum

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3091479

FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro

9 December 2018

1 reference

12 December 2020

Pyoderma gangrenosum in infancy: the youngest reported patient

1 reference

12 December 2020

A highly sensitive method to assay FK-506 levels in plasma

1 reference

12 December 2020

Effects of tetracycline on leukotaxis

1 reference

12 December 2020

FK506 and pertussis toxin distinguish growth-induced locomotor activation from attractant-stimulated locomotion in human blood lymphocytes

1 reference

12 December 2020

10.7326/0003-4819-119-7_PART_1-199310010-00008

Identifiers

DOI

1 reference

5 August 2017

1 reference

5 August 2017

1 reference